STOCK TITAN

[Form 3] Aspira Women's Health Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3

Aspira Women's Health Inc. Form 3 filed by Brian Hungerford, who is identified as Chief Financial Officer and a director, reports that no securities are beneficially owned by the reporting person as of the event date 09/02/2025. The filing is an initial statement of beneficial ownership under Section 16 and is signed by Mr. Hungerford on 09/04/2025. The form discloses the filer’s title and address and states that no non-derivative or derivative securities are owned.

Aspira Women's Health Inc. Form 3 presentata da Brian Hungerford, che è identificato come Direttore finanziario e membro del consiglio, riporta che nessun titolo è detenuto beneficiariamente dal soggetto che presenta alle date dell’evento 02/09/2025. La dichiarazione è una dichiarazione iniziale di possesso Beneficial Ownership ai sensi della Sezione 16 ed è firmata dal Sr. Hungerford il 04/09/2025. Il modulo rivela il titolo e l’indirizzo del dichiarante e afferma che non sono posseduti titoli non derivati né derivati.

Aspira Women's Health Inc. Formulario 3 presentado por Brian Hungerford, quien se identifica como Director Financiero y director, informa que ningún valor está siendo poseído de manera beneficiosa por la persona informante a la fecha del evento 09/02/2025. El formulario es una declaración inicial de propiedad beneficiosa bajo la Sección 16 y está firmado por el Sr. Hungerford el 09/04/2025. El formulario divulga el título y la dirección del declarante y señala que no se poseen valores no derivados ni derivados.

Aspira Women's Health Inc. Form 3가 Brian Hungerford에 의해 제출되었으며, 그는 최고 재무 책임자이자 이사로 확인되며, 보고 대상자가 이벤트 날짜 2025년 9월 2일실질적으로 소유한 증권이 없다고 보고합니다. 제출은 섹션 16에 따른 초기 실질 소유권 진술이며, Hungerford 씨가 2025년 9월 4일에 서명했습니다. 양식은 제출인의 직함과 주소를 공개하고 비파생 증권이나 파생 증권이 소유되지 않음을 명시합니다.

Aspira Women's Health Inc. Formulaire 3 déposé par Brian Hungerford, qui est identifié comme Directeur Financier et administrateur, indique que aucun titre n’est détenu bénéficiairement par le déclarant à la date de l’événement 02/09/2025. Le dépôt est une déclaration initiale de propriété bénéficiaire en vertu de la Section 16 et est signé par M. Hungerford le 04/09/2025. Le formulaire révèle le titre et l’adresse du déclarant et indique qu’aucun titre non dérivé ni dérivé n’est détenu.

Aspira Women's Health Inc. Form 3, eingereicht von Brian Hungerford, der als Chief Financial Officer und Direktor identifiziert wird, teilt mit, dass vom Melder keine Wertpapiere vorteilhaft gehalten werden zum Stichtag 02.09.2025. Die Einreichung ist eine erste Offenlegung des vorteilhaften Eigentums gemäß Abschnitt 16 und ist von Herrn Hungerford am 04.09.2025 unterzeichnet. Das Formular offenbart die Titel- und Adressangaben des Meldenden und besagt, dass weder nicht abgeleitete noch abgeleitete Wertpapiere gehalten werden.

تقدم Aspira Women's Health Inc. النموذج 3 من قبل برايان هنغر فورد، الذي يُعرَّف بأنه مدير الشؤون المالية وعضو مجلس الإدارة، ويُفيد بأن لا توجد أوراق مالية مملوكة بشكل مستفيد من الشخص المبلغ عنه حتى تاريخ الحدث 02/09/2025. الإخطار هو بيان ملكية مفيدة أولي بموجب القسم 16 وموقع من السيد هينغر فورد في 04/09/2025. يكشف النموذج عن عنوان ولقب المُبلغ ويذكر أنه لا توجد أوراق مالية غير مشتقة ولا مشتقة مملوكة.

Aspira Women's Health Inc. 表格3由 Brian Hungerford 提交,他被识别为 首席财务官 且为董事,报告截至事件日 2025/09/02,报告人并无受益持有的证券。 该申报是根据第16条的初始实益所有权声明,由 Hungerford 先生于 2025/09/04 签署。 表格披露了申报人的头衔和地址,并声明未持有非衍生证券或衍生证券。

Positive
  • Initial Form 3 filed disclosing officer status and contact details
  • Clear statement of no beneficial ownership as of 09/02/2025
Negative
  • None.

Aspira Women's Health Inc. Form 3 presentata da Brian Hungerford, che è identificato come Direttore finanziario e membro del consiglio, riporta che nessun titolo è detenuto beneficiariamente dal soggetto che presenta alle date dell’evento 02/09/2025. La dichiarazione è una dichiarazione iniziale di possesso Beneficial Ownership ai sensi della Sezione 16 ed è firmata dal Sr. Hungerford il 04/09/2025. Il modulo rivela il titolo e l’indirizzo del dichiarante e afferma che non sono posseduti titoli non derivati né derivati.

Aspira Women's Health Inc. Formulario 3 presentado por Brian Hungerford, quien se identifica como Director Financiero y director, informa que ningún valor está siendo poseído de manera beneficiosa por la persona informante a la fecha del evento 09/02/2025. El formulario es una declaración inicial de propiedad beneficiosa bajo la Sección 16 y está firmado por el Sr. Hungerford el 09/04/2025. El formulario divulga el título y la dirección del declarante y señala que no se poseen valores no derivados ni derivados.

Aspira Women's Health Inc. Form 3가 Brian Hungerford에 의해 제출되었으며, 그는 최고 재무 책임자이자 이사로 확인되며, 보고 대상자가 이벤트 날짜 2025년 9월 2일실질적으로 소유한 증권이 없다고 보고합니다. 제출은 섹션 16에 따른 초기 실질 소유권 진술이며, Hungerford 씨가 2025년 9월 4일에 서명했습니다. 양식은 제출인의 직함과 주소를 공개하고 비파생 증권이나 파생 증권이 소유되지 않음을 명시합니다.

Aspira Women's Health Inc. Formulaire 3 déposé par Brian Hungerford, qui est identifié comme Directeur Financier et administrateur, indique que aucun titre n’est détenu bénéficiairement par le déclarant à la date de l’événement 02/09/2025. Le dépôt est une déclaration initiale de propriété bénéficiaire en vertu de la Section 16 et est signé par M. Hungerford le 04/09/2025. Le formulaire révèle le titre et l’adresse du déclarant et indique qu’aucun titre non dérivé ni dérivé n’est détenu.

Aspira Women's Health Inc. Form 3, eingereicht von Brian Hungerford, der als Chief Financial Officer und Direktor identifiziert wird, teilt mit, dass vom Melder keine Wertpapiere vorteilhaft gehalten werden zum Stichtag 02.09.2025. Die Einreichung ist eine erste Offenlegung des vorteilhaften Eigentums gemäß Abschnitt 16 und ist von Herrn Hungerford am 04.09.2025 unterzeichnet. Das Formular offenbart die Titel- und Adressangaben des Meldenden und besagt, dass weder nicht abgeleitete noch abgeleitete Wertpapiere gehalten werden.

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Hungerford Brian

(Last) (First) (Middle)
C/O ASPIRA WOMEN'S HEALTH INC.
12117 BEE CAVES RD BLDG 3-100

(Street)
AUSTIN, TX 78738

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
09/02/2025
3. Issuer Name and Ticker or Trading Symbol
Aspira Women's Health Inc. [ AWHL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
No securities are beneficially owned.
/s/ Brian Hungerford 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does the Form 3 filed by AWH (Aspira Women's Health) indicate?

The Form 3 shows that Brian Hungerford, identified as Chief Financial Officer and director, reported no beneficial ownership of the issuer's securities as of 09/02/2025.

Who signed the Form 3 for Aspira Women's Health (symbol AWH)?

The Form 3 was signed by Brian Hungerford on 09/04/2025.

Does the Form 3 list any derivative or non-derivative securities owned?

No. The filing contains an explicit explanation: "No securities are beneficially owned."

What is the reporting person’s role at Aspira Women's Health in this filing?

The filing lists the reporting person as a company Officer (Chief Financial Officer) and a Director.

When is the event date reported on the Form 3 for AWH?

The Date of Event Requiring Statement is 09/02/2025.
Aspira Women`s Health Inc

NASDAQ:AWH

AWH Rankings

AWH Latest News

AWH Latest SEC Filings

AWH Stock Data

6.61M
17.53M
Surgical and Medical Instrument Manufacturing
In Vitro & in Vivo Diagnostic Substances
Link
US
AUSTIN